Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 2004 Oct;63(10):1212–1217. doi: 10.1136/ard.2003.016881

A prospective study of pregnant patients with rheumatoid arthritis and ankylosing spondylitis using validated clinical instruments

M Ostensen 1, L Fuhrer 1, R Mathieu 1, M Seitz 1, P Villiger 1
PMCID: PMC1754757  PMID: 15361373

Abstract

Objective: : To analyse the disease course of patients with rheumatoid arthritis (RA) and ankylosing spondylitis (AS) during and after pregnancy by validated clinical instruments for measurement of disease activity, and assess their usefulness in pregnant patients.

Methods: Included were 10 patients with RA and 9 with AS (10 pregnancies). Clinical examination and blood/urine sampling was performed before conception, at each trimester, and weeks 6, 12, and 24 post partum. Assessment of RA was by the RA Disease Activity Index (RADAI), the 44 joint count, and the Health Assessment Questionnaire; assessment of AS by the Bath Ankylosing Spondylitis Activity Index (BASDAI), the Dougados Functional and Articular Index, and a night pain index. Common for all patients were the patient's and physician's global assessment.

Results: : Most patients with RA showed sustained or increased improvement of disease activity during pregnancy. Higher disease activity scores were found in the patients with AS with a frequent increase of disease activity in the second trimester and mitigation of symptoms in the third trimester. Analysis specifically for the patient's assessment of pain showed continuously higher pain scores in the patients with AS than in those with RA. Rank correlation showed good to moderate correlation between most clinical measurements and RADAI or BASDAI, respectively. Functional indices were confounded by physiological changes of late pregnancy.

Conclusion: RA can be monitored during and after pregnancy by the swollen joint count and RADAI without interference from pregnancy related symptoms, whereas usual measures of disease activity are not always applicable in pregnant patients with AS.

Full Text

The Full Text of this article is available as a PDF (113.8 KB).

Figure 1.

Figure 1

Open in a new tab

 Disease activity in nine patients with RA before, during, and after pregnancy. Each patient is depicted by an individual symbol and colour which is kept in all figures (A–D). The thick, solid line in figs 1A, B, and C is the median value for the group. (A) Swollen joint count; (B) RADAI score; (C) patient's global assessment; (D) the RADAI score and CRP measurements of the two patients with RA with active disease during pregnancy. Arrows depict the time of either intra-articular injection of corticosteroids or start of disease modifying treatment. *wks pp, weeks post partum.

Figure 2.

Figure 2

Open in a new tab

 Disease activity in nine patients with AS before, during, and after 10 pregnancies. Each patient is depicted by an individual symbol and colour which is kept in all figures. The thick, solid line in figs 2A–D is the median value for the group. (A) Dougados joint index; (B) BASDAI score; (C) patient's global assessment; (D) morning stiffness score (items 5 and 6 of the BASDAI). *wks pp, weeks post partum.

Figure 3.

Figure 3

Open in a new tab

 Comparison of disease activity indices in nine patients with RA (red line) and nine patients with AS (blue line) during and after pregnancy. Median values of the patient's global score (A), the physician global score (B), and a pain score (C) are given. The pain score for patients with RA is item 3 of the RADAI: How strong is your arthritis pain today? and item 2 of the BASDAI for patients with AS: How would you describe the overall level of AS neck, back, or hip pain you have had? (D) Consumption of NSAID or paracetamol, or both, in patients with RA (filled blocks) and AS (open blocks) during the observation period.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alavi A., Arden N., Spector T. D., Axford J. S. Immunoglobulin G glycosylation and clinical outcome in rheumatoid arthritis during pregnancy. J Rheumatol. 2000 Jun;27(6):1379–1385. [PubMed] [Google Scholar]
  2. Anderson J. J., Baron G., van der Heijde D., Felson D. T., Dougados M. Ankylosing spondylitis assessment group preliminary definition of short-term improvement in ankylosing spondylitis. Arthritis Rheum. 2001 Aug;44(8):1876–1886. doi: 10.1002/1529-0131(200108)44:8<1876::AID-ART326>3.0.CO;2-F. [DOI] [PubMed] [Google Scholar]
  3. Arnett F. C., Edworthy S. M., Bloch D. A., McShane D. J., Fries J. F., Cooper N. S., Healey L. A., Kaplan S. R., Liang M. H., Luthra H. S. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988 Mar;31(3):315–324. doi: 10.1002/art.1780310302. [DOI] [PubMed] [Google Scholar]
  4. Barrett J. H., Brennan P., Fiddler M., Silman A. J. Does rheumatoid arthritis remit during pregnancy and relapse postpartum? Results from a nationwide study in the United Kingdom performed prospectively from late pregnancy. Arthritis Rheum. 1999 Jun;42(6):1219–1227. doi: 10.1002/1529-0131(199906)42:6<1219::AID-ANR19>3.0.CO;2-G. [DOI] [PubMed] [Google Scholar]
  5. Dougados M., Gueguen A., Nakache J. P., Nguyen M., Mery C., Amor B. Evaluation of a functional index and an articular index in ankylosing spondylitis. J Rheumatol. 1988 Feb;15(2):302–307. [PubMed] [Google Scholar]
  6. Dougados M., van der Linden S., Juhlin R., Huitfeldt B., Amor B., Calin A., Cats A., Dijkmans B., Olivieri I., Pasero G. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum. 1991 Oct;34(10):1218–1227. doi: 10.1002/art.1780341003. [DOI] [PubMed] [Google Scholar]
  7. Garrett S., Jenkinson T., Kennedy L. G., Whitelock H., Gaisford P., Calin A. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol. 1994 Dec;21(12):2286–2291. [PubMed] [Google Scholar]
  8. Gerecz-Simon E. M., Tunks E. R., Heale J. A., Kean W. F., Buchanan W. W. Measurement of pain threshold in patients with rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, and healthy controls. Clin Rheumatol. 1989 Dec;8(4):467–474. doi: 10.1007/BF02032098. [DOI] [PubMed] [Google Scholar]
  9. Gilleard Wendy, Crosbie Jack, Smith Richard. Effect of pregnancy on trunk range of motion when sitting and standing. Acta Obstet Gynecol Scand. 2002 Nov;81(11):1011–1020. doi: 10.1034/j.1600-0412.2002.811104.x. [DOI] [PubMed] [Google Scholar]
  10. Goldsmith L. T., Weiss G., Steinetz B. G. Relaxin and its role in pregnancy. Endocrinol Metab Clin North Am. 1995 Mar;24(1):171–186. [PubMed] [Google Scholar]
  11. Gran J. T., Ostensen M. Spondyloarthritides in females. Baillieres Clin Rheumatol. 1998 Nov;12(4):695–715. doi: 10.1016/s0950-3579(98)80045-9. [DOI] [PubMed] [Google Scholar]
  12. Hainline B. Low-back pain in pregnancy. Adv Neurol. 1994;64:65–76. [PubMed] [Google Scholar]
  13. Hawley D. J., Wolfe F. Sensitivity to change of the health assessment questionnaire (HAQ) and other clinical and health status measures in rheumatoid arthritis: results of short-term clinical trials and observational studies versus long-term observational studies. Arthritis Care Res. 1992 Sep;5(3):130–136. doi: 10.1002/art.1790050304. [DOI] [PubMed] [Google Scholar]
  14. Hultgren S., Broman J. E., Gudbjörnsson B., Hetta J., Lindqvist U. Sleep disturbances in outpatients with ankylosing spondylitisa questionnaire study with gender implications. Scand J Rheumatol. 2000;29(6):365–369. doi: 10.1080/030097400447561. [DOI] [PubMed] [Google Scholar]
  15. Incel Nurgül Arinci, Erdem H. Rana, Ozgocmen Salih, Catal Sema Atalay, Yorgancioglu Z. Rezan. Pain pressure threshold values in ankylosing spondylitis. Rheumatol Int. 2002 Jun 19;22(4):148–150. doi: 10.1007/s00296-002-0211-1. [DOI] [PubMed] [Google Scholar]
  16. Ireland M. L., Ott S. M. The effects of pregnancy on the musculoskeletal system. Clin Orthop Relat Res. 2000 Mar;(372):169–179. doi: 10.1097/00003086-200003000-00019. [DOI] [PubMed] [Google Scholar]
  17. Mckee M. D., Cunningham M., Jankowski K. R., Zayas L. Health-related functional status in pregnancy: relationship to depression and social support in a multi-ethnic population. Obstet Gynecol. 2001 Jun;97(6):988–993. doi: 10.1016/s0029-7844(01)01377-1. [DOI] [PubMed] [Google Scholar]
  18. Neely N. T., Persellin R. H. Activity of rheumatoid arthritis during pregnancy. Tex Med. 1977 Aug;73(8):59–63. [PubMed] [Google Scholar]
  19. Nelson J. L., Hughes K. A., Smith A. G., Nisperos B. B., Branchaud A. M., Hansen J. A. Maternal-fetal disparity in HLA class II alloantigens and the pregnancy-induced amelioration of rheumatoid arthritis. N Engl J Med. 1993 Aug 12;329(7):466–471. doi: 10.1056/NEJM199308123290704. [DOI] [PubMed] [Google Scholar]
  20. Ostensen M., Husby G. A prospective clinical study of the effect of pregnancy on rheumatoid arthritis and ankylosing spondylitis. Arthritis Rheum. 1983 Sep;26(9):1155–1159. doi: 10.1002/art.1780260915. [DOI] [PubMed] [Google Scholar]
  21. Ostensen M., Husby G. Ankylosing spondylitis and pregnancy. Rheum Dis Clin North Am. 1989 May;15(2):241–254. [PubMed] [Google Scholar]
  22. Ostensen M., Ostensen H. Ankylosing spondylitis--the female aspect. J Rheumatol. 1998 Jan;25(1):120–124. [PubMed] [Google Scholar]
  23. Ostensen M. Pregnancy in psoriatic arthritis. Scand J Rheumatol. 1988;17(1):67–70. doi: 10.3109/03009748809098763. [DOI] [PubMed] [Google Scholar]
  24. Pinals R. S., Masi A. T., Larsen R. A. Preliminary criteria for clinical remission in rheumatoid arthritis. Arthritis Rheum. 1981 Oct;24(10):1308–1315. doi: 10.1002/art.1780241012. [DOI] [PubMed] [Google Scholar]
  25. Quinn C., Mulpeter K., Casey E. B., Feighery C. F. Changes in levels of IgM RF and alpha 2 PAG correlate with increased disease activity in rheumatoid arthritis during the puerperium. Scand J Rheumatol. 1993;22(6):273–279. doi: 10.3109/03009749309095138. [DOI] [PubMed] [Google Scholar]
  26. Reay Jones N. H. J., Healy J. C., King L. J., Saini S., Shousha S., Allen-Mersh T. G. Pelvic connective tissue resilience decreases with vaginal delivery, menopause and uterine prolapse. Br J Surg. 2003 Apr;90(4):466–472. doi: 10.1002/bjs.4065. [DOI] [PubMed] [Google Scholar]
  27. Stucki G., Liang M. H., Stucki S., Brühlmann P., Michel B. A. A self-administered rheumatoid arthritis disease activity index (RADAI) for epidemiologic research. Psychometric properties and correlation with parameters of disease activity. Arthritis Rheum. 1995 Jun;38(6):795–798. doi: 10.1002/art.1780380612. [DOI] [PubMed] [Google Scholar]
  28. Unger A., Kay A., Griffin A. J., Panayi G. S. Disease activity and pregnancy associated alpha 2-glycoprotein in rheumatoid arthritis during pregnancy. Br Med J (Clin Res Ed) 1983 Mar 5;286(6367):750–752. doi: 10.1136/bmj.286.6367.750. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES